Top Page Links

Brexit Talks Must Prioritize Patients: EFPIA Chief


 

  • Per EurActiv, Stefan Oschmann, President of the European Federation of Pharmaceutical Industries and Associations and CEO of Merck KGaA, warns that Brexit talks have not sufficiently addressed the potential peril for patients.

 

  • With 1 billion packs of medicines traversing the border between the UK and EU annually, Oschmann argues that member states must take more concrete steps to avoid medicine shortages and increase business uncertainty in the wake of Brexit.